Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Selling, General & Admin	1.32	1.06	0.04
Operating Expenses	1.32	1.06	0.04
Operating Income	-1.32	-1.06	-0.04
Interest & Investment Income	3.31	3.62	0.3
Pretax Income	1.98	2.55	0.26
Net Income	1.98	2.55	0.26
Net Income to Common	1.98	2.55	0.26
Net Income Growth	-	892.75%	-
Shares Outstanding (Basic)	-	9	2
Shares Outstanding (Diluted)	-	9	2
Shares Change (YoY)	-	304.07%	-
EPS (Basic)	-	0.28	-
EPS (Diluted)	-	0.28	-
EBIT	-1.32	-1.06	-0.04

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q